High risk of adverse birth outcomes among adolescents living with HIV in Botswana compared to adult women living with HIV and adolescents without HIV.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
30 Apr 2022
Historique:
received: 18 07 2021
accepted: 07 04 2022
entrez: 30 4 2022
pubmed: 1 5 2022
medline: 4 5 2022
Statut: epublish

Résumé

Adolescent girls are three times more likely to be living with HIV than boys of the same age. Prior studies have found associations between adolescent pregnancies and increased maternal morbidity and infant mortality, but few studies have assessed the impact of HIV infection on maternal and infant outcomes in adolescents. The Tsepamo Study abstracts maternal and infant data from obstetric records in government maternity wards in Botswana. We assessed maternal complications and adverse birth outcomes for all singleton pregnancies from August 2014 to August 2020 at eighteen Tsepamo sites among adolescents (defined as 10-19 years of age) and adults (defined as 20-35 years of age), by HIV status. Univariate and multivariate logistic regression using a complete case analysis method were used to evaluate differences in outcomes. This analysis included 142,258 singleton births, 21,133 (14.9%) to adolescents and 121,125 (85.1%) to adults. The proportion of adults living with HIV (N = 22,114, 22.5%) was higher than adolescents (N = 1593, 7.6%). The proportion of most adverse birth outcomes was higher in adolescents. Among adolescents, those with HIV had increased likelihoods of anemia (aOR = 1.89, 95%CI 1.66, 2.15) and cesarean sections (aOR = 1.49, 95%CI 1.3,1.72), and infants with preterm birth (aOR = 1.15, 95%CI 1.0, 1.32), very preterm birth (aOR = 1.35, 95%CI 1.0,1.8), small for gestational age (aOR = 1.37, 95%CI 1.20,1.58), and very small for gestational age (aOR = 1.46, 95%CI 1.20, 1.79). Adolescent pregnancy and adolescent HIV infection remain high in Botswana. Adolescents have higher risk of adverse maternal and infant birth outcomes than adults, with the worst outcomes among adolescents living with HIV. Linking HIV prevention and family planning strategies for this age group may help minimize the number of infants with poor birth outcomes among this already vulnerable population.

Sections du résumé

BACKGROUND BACKGROUND
Adolescent girls are three times more likely to be living with HIV than boys of the same age. Prior studies have found associations between adolescent pregnancies and increased maternal morbidity and infant mortality, but few studies have assessed the impact of HIV infection on maternal and infant outcomes in adolescents.
METHODS METHODS
The Tsepamo Study abstracts maternal and infant data from obstetric records in government maternity wards in Botswana. We assessed maternal complications and adverse birth outcomes for all singleton pregnancies from August 2014 to August 2020 at eighteen Tsepamo sites among adolescents (defined as 10-19 years of age) and adults (defined as 20-35 years of age), by HIV status. Univariate and multivariate logistic regression using a complete case analysis method were used to evaluate differences in outcomes.
RESULTS RESULTS
This analysis included 142,258 singleton births, 21,133 (14.9%) to adolescents and 121,125 (85.1%) to adults. The proportion of adults living with HIV (N = 22,114, 22.5%) was higher than adolescents (N = 1593, 7.6%). The proportion of most adverse birth outcomes was higher in adolescents. Among adolescents, those with HIV had increased likelihoods of anemia (aOR = 1.89, 95%CI 1.66, 2.15) and cesarean sections (aOR = 1.49, 95%CI 1.3,1.72), and infants with preterm birth (aOR = 1.15, 95%CI 1.0, 1.32), very preterm birth (aOR = 1.35, 95%CI 1.0,1.8), small for gestational age (aOR = 1.37, 95%CI 1.20,1.58), and very small for gestational age (aOR = 1.46, 95%CI 1.20, 1.79).
CONCLUSIONS CONCLUSIONS
Adolescent pregnancy and adolescent HIV infection remain high in Botswana. Adolescents have higher risk of adverse maternal and infant birth outcomes than adults, with the worst outcomes among adolescents living with HIV. Linking HIV prevention and family planning strategies for this age group may help minimize the number of infants with poor birth outcomes among this already vulnerable population.

Identifiants

pubmed: 35490225
doi: 10.1186/s12884-022-04687-y
pii: 10.1186/s12884-022-04687-y
pmc: PMC9055710
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

372

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD080471
Pays : United States
Organisme : NIH/NICHD
ID : K23 HD088230-01A1
Organisme : NIAID NIH HHS
ID : K24 AI131924
Pays : United States
Organisme : NIH/NICHD
ID : 5R01HD080471-05
Organisme : NIH/NIAID
ID : 5K24AI131924-03
Organisme : FIC NIH HHS
ID : D43 TW010543
Pays : United States
Organisme : NICHD NIH HHS
ID : K01 HD100222
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Am J Public Health. 2002 Aug;92(8):1323-30
pubmed: 12144992
Am J Obstet Gynecol. 2015 Jul;213(1):95.e1-95.e8
pubmed: 25935776
Lancet Glob Health. 2018 Jul;6(7):e804-e810
pubmed: 29880310
N Engl J Med. 1995 Apr 27;332(17):1113-7
pubmed: 7700283
MMWR Morb Mortal Wkly Rep. 2004 Nov 26;53(46):1083-6
pubmed: 15565017
BMC Pregnancy Childbirth. 2020 Jun 1;20(1):339
pubmed: 32487101
Einstein (Sao Paulo). 2015 Oct-Dec;13(4):618-26
pubmed: 26061075
J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):252-258
pubmed: 32539088
BMC Public Health. 2018 Oct 4;18(1):1158
pubmed: 30286746
J Obstet Gynaecol Can. 2015 Apr;37(4):302-309
pubmed: 26001682
J Perinat Med. 1999;27(3):199-203
pubmed: 10503182
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):235-241
pubmed: 32195745
BMC Womens Health. 2012 Oct 06;12:34
pubmed: 23039966
Niger J Med. 2011 Oct-Dec;20(4):414-20
pubmed: 22288314
Obstet Gynecol. 1989 Jul;74(1):6-12
pubmed: 2733943
Arch Gynecol Obstet. 2012 Mar;285(3):573-7
pubmed: 21789518
JAMA Pediatr. 2017 Oct 2;171(10):e172222
pubmed: 28783807
J Int AIDS Soc. 2021 Jun;24(6):e25763
pubmed: 34176240
Lancet. 1988 Mar 26;1(8587):701-2
pubmed: 2895225
Eur J Obstet Gynecol Reprod Biol. 1995 Mar;59(1):17-20
pubmed: 7781855
Am J Obstet Gynecol. 2005 Feb;192(2):342-9
pubmed: 15695970
Sci Rep. 2018 Dec 24;8(1):18072
pubmed: 30584240
Am J Obstet Gynecol. 2017 Dec;217(6):684.e1-684.e17
pubmed: 29031892
Lancet HIV. 2016 Jan;3(1):e33-48
pubmed: 26762992
Paediatr Perinat Epidemiol. 2019 Jan;33(1):88-99
pubmed: 30516287
Indian J Pediatr. 2007 Oct;74(10):927-31
pubmed: 17978452
Ned Tijdschr Geneeskd. 1993 Dec 4;137(49):2536-40
pubmed: 8272140
Lancet Infect Dis. 2014 Jul;14(7):627-39
pubmed: 24406145
EClinicalMedicine. 2020 Nov 05;29-30:100615
pubmed: 33437946
Eur J Obstet Gynecol Reprod Biol. 2009 Dec;147(2):151-6
pubmed: 19733429
Br J Obstet Gynaecol. 1998 Aug;105(8):836-48
pubmed: 9746375
PLoS One. 2019 Jun 13;14(6):e0218259
pubmed: 31194833
J Adolesc Health Care. 1989 Jan;10(1):16-22
pubmed: 2921184
Acta Obstet Gynecol Scand. 2012 Sep;91(9):1114-8
pubmed: 22620274
Reprod Health. 2015;12 Suppl 2:S8
pubmed: 26063350
Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:170-1
pubmed: 16641854
Paediatr Perinat Epidemiol. 1989 Oct;3(4):357-66
pubmed: 2587406
Int J Epidemiol. 2007 Apr;36(2):368-73
pubmed: 17213208
Am J Dis Child. 1987 Oct;141(10):1053-9
pubmed: 3630989
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):428-36
pubmed: 26379069
J Pediatr Adolesc Gynecol. 2016 Aug;29(4):367-71
pubmed: 26762668

Auteurs

Maya Jackson-Gibson (M)

Feinberg School of Medicine Northwestern University, Chicago, Illinois, USA. maya.jackson-gibson@northwestern.edu.

Rebecca Zash (R)

Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Aamirah Mussa (A)

Botswana-Harvard Partnership AIDS Institute, Gaborone, Botswana.

Ellen C Caniglia (EC)

University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Modiegi Diseko (M)

Botswana-Harvard Partnership AIDS Institute, Gaborone, Botswana.

Gloria Mayondi (G)

Botswana-Harvard Partnership AIDS Institute, Gaborone, Botswana.

Judith Mabuta (J)

Botswana-Harvard Partnership AIDS Institute, Gaborone, Botswana.

Chelsea Morroni (C)

MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, Scotland.

Mompati Mmalane (M)

Botswana-Harvard Partnership AIDS Institute, Gaborone, Botswana.

Shahin Lockman (S)

Brigham and Women's Hospital, Boston, Massachusetts, USA.

Joseph Makhema (J)

Botswana-Harvard Partnership AIDS Institute, Gaborone, Botswana.

Roger L Shapiro (RL)

Harvard T. H Chan School of Public Health, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH